Anticancer Research · 2017 · 26 citations · 24 references
MedicineCancer BiologyOncologyCell TherapyMolecular OncologyTumor ProgressionCancer-associated FibroblastsMalignant NeoplasmsTumor Growth KineticsAtmospheric Pressure Plasma SourcesCell Proliferation IndicesCell Proliferation KineticsCold Plasma TreatmentNonthermal Plasma SourcesOsteosarcoma TreatmentTumor Cell ProliferationTumor Proliferation Assessment
BACKGROUND/AIM: Cold atmospheric plasma (CAP) attenuates tumor cell proliferation and induces apoptosis in various cell lines. While exerting marginal effects on non-neoplastic cells this unfolds promising applications in cancer therapy. The aim of the study was to analyse the effects of different CAP sources and application times on osteosarcoma (OS) cells and non-malignant fibroblast cell proliferation. MATERIALS AND METHODS: U2-OS and 3-T-3 fibroblasts were treated with three different approved medical devices. Carrier gas-treated cells served as controls. Cell proliferation was determined by viable cell count at different time points after treatment. RESULTS: Control exposed U2-OS and 3-T-3 cells exhibited characteristic cell growth. CAP application of U2-OS and 3-T-3 cells attenuated proliferation rates up to 98%. Attenuation rates varied between cell lines, plasma sources and application times. CONCLUSION: CAP treatment attenuates cell proliferation of OS cancer cells and fibroblasts in a treatment time-dependent manner, whereby U2-OS cells appeared more sensitive to CAP treatment as 3T3 fibroblasts after 10 sec of treatment.
24
Effects of Non-Thermal Plasma on Mammalian Cells
Sameer Kalghatgi, Crystal Kelly, Ekaterina Cerchar et al. · PLoS ONE · 2011 · 508 citations · Full text
A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era
Daniel C. Allison, Scott C. Carney, Elke R. Ahlmann et al. · Sarcoma · 2012 · 406 citations · Full text
Hak Jun Ahn, Kang‐Il Kim, Eunpyo Moon et al. · PLoS ONE · 2011 · 342 citations · Full text
Tissue Tolerable Plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo
Lars Ivo Partecke, Katja Evert, Jan Haugk et al. · BMC Cancer · 2012 · 250 citations · Full text
Medicine, Cancer Biology, Oncology +10